The DOI matches its Crossref record.
Physiologic, subjective, and behavioral effects of amphetamine, methamphetamine, ephedrine, phenmetrazine, and methylphenidate in man
Abstract
Five centrally acting sympathomimetic amines, d‐amphetamine, d‐methamphetamine, ephedrine, phenmetrazine, and methylphenidate, were studied in man. All of these agents increased blood pressure and respiratory rate, produced similar types of subiective changes, and increased the excretion of epinephrine. With regard to these parameters, there was a high concordance between estimates of their relative potencies. The concordance between the potency estimates for the different parameters suggests, but does not prove, that these five agents share a common mode of central action. Further, if the peripheral modes of action as elucidated by animal studies are true for man, this study suggests that it is unlikely that their central actions in man are a consequence of the release of norepinephrine in the brain.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Griffiths, R. R., Richards, W. A., McCann, U., & Jesse, R. (2006) · Psychopharmacology · doi:10.1007/s00213-006-0457-5 · Cited by 1,684
Limbic-cortical dysregulation: a proposed model of depression
(1997) · The Journal of Neuropsychiatry and Clinical Neurosciences · doi:10.1176/jnp.9.3.471 · Cited by 1,585
Psilocybin-assisted treatment for alcohol dependence: A proof-of-concept study
Bogenschutz, M. P., Forcehimes, A. A., Pommy, J. A., Wilcox, C. E., Barbosa, P., & Strassman, R. J. (2015) · Journal of Psychopharmacology · doi:10.1177/0269881114565144 · Cited by 1,151
Rothman, R. B., Baumann, M. H., Dersch, C. M., Romero, D. V., Rice, K. C., Carroll, F. I., & Partilla, J. S. (2001) · Synapse · doi:10.1002/1098-2396(20010101)39:1<32::aid-syn5>3.0.co;2-3 · Cited by 938
Psilocybin occasioned mystical-type experiences: immediate and persisting dose-related effects
Griffiths, R. R., Johnson, M. W., Richards, W. A., Richards, B. D., McCann, U., & Jesse, R. (2011) · Psychopharmacology · doi:10.1007/s00213-011-2358-5 · Cited by 932
DELAY OR PROBABILITY DISCOUNTING IN A MODEL OF IMPULSIVE BEHAVIOR: EFFECT OF ALCOHOL
Richards, J. B., Zhang, L., Mitchell, S. H., & de Wit, H. (1999) · Journal of the Experimental Analysis of Behavior · doi:10.1901/jeab.1999.71-121 · Cited by 791
Clinical pharmacology of buprenorphine: Ceiling effects at high doses
Walsh, S. L., Preston, K. L., Stitzer, M. L., Cone, E. J., & Bigelow, G. E. (1994) · Clinical Pharmacology and Therapeutics · doi:10.1038/clpt.1994.71 · Cited by 773
A review of the clinical pharmacology of methamphetamine
Cruickshank, C. C., & Dyer, K. R. (2009) · Addiction · doi:10.1111/j.1360-0443.2009.02564.x · Cited by 769
Pharmacological characterization of designer cathinones in vitro
Simmler, L., Buser, T., Donzelli, M., Schramm, Y., Dieu, L., Huwyler, J., Chaboz, S., Hoener, M., & Liechti, M. (2013) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2012.02145.x · Cited by 672
Secondary Mania: Manic Syndromes Associated With Antecedent Physical Illness or Drugs
Krauthammer, C. (1978) · Archives of General Psychiatry · doi:10.1001/archpsyc.1978.01770350059005 · Cited by 648
Provocative tests with psychostimulant drugs in schizophrenia
Lieberman, J. A., Kane, J. M., & Alvir, J. (1987) · Psychopharmacology · doi:10.1007/bf00216006 · Cited by 532
Acute administration of d-amphetamine decreases impulsivity in healthy volunteers
de Wit, H. (2002) · Neuropsychopharmacology · doi:10.1016/s0893-133x(02)00343-3 · Cited by 436
Approved and Investigational Uses of Modafinil: An Evidence-Based Review
Kumar, R. (2008) · Drugs · doi:10.2165/00003495-200868130-00003 · Cited by 415
Acute Effects of Lysergic Acid Diethylamide in Healthy Subjects
Schmid, Y., Enzler, F., Gasser, P., Grouzmann, E., Preller, K. H., Vollenweider, F. X., Brenneisen, R., Müller, F., Borgwardt, S., & Liechti, M. E. (2015) · Biological Psychiatry · doi:10.1016/j.biopsych.2014.11.015 · Cited by 411
Riba, J., Valle, M., Urbano, G., Yritia, M., Morte, A., & Barbanoj, M. J. (2003) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.103.049882 · Cited by 390
Effects of THC on Behavioral Measures of Impulsivity in Humans
McDonald, J., Schleifer, L., Richards, J. B., & de Wit, H. (2003) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300176 · Cited by 368
Assessing the abuse potential of methylphenidate in nonhuman and human subjects: a review
Kollins, S. H., MacDonald, E. K., & Rush, C. R. (2001) · Pharmacology Biochemistry and Behavior · doi:10.1016/s0091-3057(01)00464-6 · Cited by 365
Mas, M., Farré, M., de la Torre, R., Roset, P. N., Segura, J. O., & Camí, J. (1999) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)34877-3 · Cited by 362
Tremblay, L. K., Naranjo, C. A., Graham, S. J., Herrmann, N., Mayberg, H. S., Hevenor, S., & Busto, U. E. (2005) · Archives of General Psychiatry · doi:10.1001/archpsyc.62.11.1228 · Cited by 340
Karst, M., Salim, K., Burstein, S., Conrad, I., Hoy, L., & Schneider, U. (2003) · JAMA · doi:10.1001/jama.290.13.1757 · Cited by 340
Crisostomo, E. A., Duncan, P. W., Propst, M., Dawson, D. V., & Davis, J. N. (1988) · Annals of Neurology · doi:10.1002/ana.410230117 · Cited by 340
Association between A2a receptor gene polymorphisms and caffeine-induced anxiety
Alsene, K., Deckert, J., Sand, P., & de Wit, H. (2003) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300232 · Cited by 334
Cardiovascular and Subjective Effects of Intravenous Cocaine Administration in Humans
Fischman, M. W. (1976) · Archives of General Psychiatry · doi:10.1001/archpsyc.1976.01770080101010 · Cited by 327
Mirthful laughter induced by subthalamic nucleus stimulation
Krack, P., Kumar, R., Ardouin, C., Dowsey, P. L., McVicker, J. M., Benabid, A., & Pollak, P. (2001) · Movement Disorders · doi:10.1002/mds.1174 · Cited by 304
Martin-Santos, R., A. Crippa, J., Batalla, A., Bhattacharyya, S., Atakan, Z., Borgwardt, S., Allen, P., Seal, M., Langohr, K., Farre, M., et al. (2012) · Current Pharmaceutical Design · doi:10.2174/138161212802884780 · Cited by 295
Jasinski, D. R., & Kovačević-Ristanović, R. (2000) · Clinical Neuropharmacology · doi:10.1097/00002826-200005000-00004 · Cited by 292
Self-citationCocaine psychoses: a continuum model
(1975) · American Journal of Psychiatry · doi:10.1176/ajp.132.3.225 · Cited by 288
Funkiewiez, A., Ardouin, C., Krack, P., Fraix, V., Van Blercom, N., Xie, J., Moro, E., Benabid, A., & Pollak, P. (2003) · Movement Disorders · doi:10.1002/mds.10441 · Cited by 264
Amphetamine‐like effects in humans of the khat alkaloid cathinone.
Brenneisen, R., Fisch, H., Koelbing, U., Geisshusler, S., & Kalix, P. (1990) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.1990.tb05447.x · Cited by 261
Enadoline, a selective kappa opioid agonist: comparison with butorphanol and hydromorphone in humans
Walsh, S., Strain, E., Abreu, M., & Bigelow, G. (2001) · Psychopharmacology · doi:10.1007/s002130100788 · Cited by 258
The drug effects questionnaire: psychometric support across three drug types
Morean, M. E., de Wit, H., King, A. C., Sofuoglu, M., Rueger, S. Y., & O’Malley, S. S. (2013) · Psychopharmacology · doi:10.1007/s00213-012-2954-z · Cited by 252
Distinct acute effects of LSD, MDMA, and d-amphetamine in healthy subjects
Holze, F., Vizeli, P., Müller, F., Ley, L., Duerig, R., Varghese, N., Eckert, A., Borgwardt, S., & Liechti, M. E. (2020) · Neuropsychopharmacology · doi:10.1038/s41386-019-0569-3 · Cited by 247
Differential subjective effects of D-amphetamine by gender, hormone levels and menstrual cycle phase
White, T. L., Justice, A. J. H., & de Wit, H. (2002) · Pharmacology Biochemistry and Behavior · doi:10.1016/s0091-3057(02)00818-3 · Cited by 248
Increased frontal and paralimbic activation following ayahuasca, the pan-amazonian inebriant
Riba, J., Romero, S., Grasa, E., Mena, E., Carrió, I., & Barbanoj, M. J. (2006) · Psychopharmacology · doi:10.1007/s00213-006-0358-7 · Cited by 241
“The ARCI (Martin et al. 1971) consists of five scales or groups: MBG, morphine–benzedrine group, measuring euphoria and positive mood; PCAG, pentobarbital– chlorpromazine–alcohol group, measuring sedation; LSD, lysergic acid diethylamide scale, measuring somatic– dysphoric effects; BG, the…”
MethodCamí, J., Farré, M., Mas, M., Roset, P. N., Poudevida, S., Mas, A., San, L., & de la Torre, R. (2000) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-200008000-00010 · Cited by 234
Childs, E., & de Wit, H. (2006) · Psychopharmacology · doi:10.1007/s00213-006-0341-3 · Cited by 219
Justice, A. J. H., & de Wit, H. (1999) · Psychopharmacology · doi:10.1007/s002130051033 · Cited by 199
Valle, M., Maqueda, A. E., Rabella, M., Rodríguez-Pujadas, A., Antonijoan, R. M., Romero, S., Alonso, J. F., Mañanas, M. À., Barker, S., Friedlander, P., et al. (2016) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2016.03.012 · Cited by 173
Early pharmacokinetics and clinical effects of oral d-amphetamine in normal subjects
Angrist, B., Corwin, J., Bartlik, B., & Cooper, T. (1987) · Biological Psychiatry · doi:10.1016/0006-3223(87)90070-9 · Cited by 171
Pattern of use and subjective effects of Salvia divinorum among recreational users
González, D., Riba, J., Bouso, J. C., Gómez-Jarabo, G., & Barbanoj, M. J. (2006) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2006.04.001 · Cited by 163
Tancer, M., & Johanson, C.-E. (2003) · Drug and Alcohol Dependence · doi:10.1016/s0376-8716(03)00172-8 · Cited by 153
Jasinski, D., & Krishnan, S. (2009) · Journal of Psychopharmacology · doi:10.1177/0269881109103113 · Cited by 149
Self-citationMDMA enhances “mind reading” of positive emotions and impairs “mind reading” of negative emotions
Hysek, C. M., Domes, G., & Liechti, M. E. (2012) · Psychopharmacology · doi:10.1007/s00213-012-2645-9 · Cited by 144
Pharmacology of ayahuasca administered in two repeated doses
dos Santos, R. G., Grasa, E., Valle, M., Ballester, M. R., Bouso, J. C., Nomdedéu, J. F., Homs, R., Barbanoj, M. J., & Riba, J. (2012) · Psychopharmacology · doi:10.1007/s00213-011-2434-x · Cited by 141
Wachtel, S. R., Ortengren, A., & Wit, H. D. (2002) · Drug and Alcohol Dependence · doi:10.1016/s0376-8716(02)00104-7 · Cited by 138
Dolder, P. C., Müller, F., Schmid, Y., Borgwardt, S. J., & Liechti, M. E. (2018) · Psychopharmacology · doi:10.1007/s00213-017-4650-5 · Cited by 117
Mason, B. J., Light, J. M., Williams, L. D., & Drobes, D. J. (2009) · Addiction Biology · doi:10.1111/j.1369-1600.2008.00133.x · Cited by 115
Tancer, M., & Johanson, C.-E. (2006) · Psychopharmacology · doi:10.1007/s00213-006-0576-z · Cited by 113
Hamidovic, A., Dlugos, A., Skol, A., Palmer, A. A., & de Wit, H. (2009) · Experimental and Clinical Psychopharmacology · doi:10.1037/a0017840 · Cited by 108
Metrik, J., Rohsenow, D. J., Monti, P. M., McGeary, J., Cook, T. A. R., de Wit, H., Haney, M., & Kahler, C. W. (2009) · Experimental and Clinical Psychopharmacology · doi:10.1037/a0016502 · Cited by 107
Jasinski, D., & Krishnan, S. (2009) · Journal of Psychopharmacology · doi:10.1177/0269881108093841 · Cited by 100
Self-citationPsychometric assessment of the Hallucinogen Rating Scale☆
Riba, J., Rodrı́guez-Fornells, A., Strassman, R. J., & Barbanoj, M. J. (2001) · Drug and Alcohol Dependence · doi:10.1016/s0376-8716(00)00175-7 · Cited by 88
Abuse liability assessment of atomoxetine in a drug-abusing population
Jasinski, D. R., Faries, D. E., Moore, R. J., Schuh, L. M., & Allen, A. J. (2008) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2008.01.008 · Cited by 87
Self-citationVariability in subjective responses to cocaine: initial experiences of college students
Davidson, E. S., Finch, J. F., & Schenk, S. (1993) · Addictive Behaviors · doi:10.1016/0306-4603(93)90062-e · Cited by 86
Bupropion improves attention but does not affect impulsive behavior in healthy young adults.
Acheson, A., & de Wit, H. (2008) · Experimental and Clinical Psychopharmacology · doi:10.1037/1064-1297.16.2.113 · Cited by 82
Middleton, L. S., Nuzzo, P. A., Lofwall, M. R., Moody, D. E., & Walsh, S. L. (2011) · Addiction · doi:10.1111/j.1360-0443.2011.03424.x · Cited by 77
Cardiovascular Responses of Hyperactive Children to Methylphenidate
Ballard, J. E. (1976) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1976.03270260026021 · Cited by 72
Behavioral and subjective effects of D-amphetamine and modafinil in healthy adults.
Makris, A. P., Rush, C. R., Frederich, R. C., Taylor, A. C., & Kelly, T. H. (2007) · Experimental and Clinical Psychopharmacology · doi:10.1037/1064-1297.15.2.123 · Cited by 68
Asghar, S. J., Tanay, V. A. M. I., Baker, G. B., Greenshaw, A., & Silverstone, P. H. (2003) · Human Psychopharmacology: Clinical and Experimental · doi:10.1002/hup.480 · Cited by 64
Alprazolam absorption kinetics affects abuse liability
Mumford, G. K., Evans, S. M., Fleishaker, J. C., & Griffiths, R. R. (1995) · Clinical Pharmacology & Therapeutics · doi:10.1016/0009-9236(95)90162-0 · Cited by 63
Johanson, C.-E., Kilbey, M., Gatchalian, K., & Tancer, M. (2006) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2005.05.003 · Cited by 58
Pain measurements and side effect profile of the novel cannabinoid ajulemic acid
Salim, K., Schneider, U., Burstein, S., Hoy, L., & Karst, M. (2005) · Neuropharmacology · doi:10.1016/j.neuropharm.2005.02.010 · Cited by 58
Effects of d-amphetamine in human models of information processing and inhibitory control
Fillmore, M. T., Kelly, T. H., & Martin, C. A. (2005) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2004.07.013 · Cited by 53
Barbier, A. J., Hilhorst, M., Vliet, A. V., Snyder, P., Palfreyman, M. G., Gawryl, M., Dgetluck, N., Massaro, M., Tiessen, R., Timmerman, W., et al. (2015) · Clinical Therapeutics · doi:10.1016/j.clinthera.2014.09.013 · Cited by 51
“Vz/F, L, mean (%CV) 1740 (37) 1970 (28) 1680 (10) 1950 (13) 1990 (14) 1810 (16)”
Adolescents are more sensitive than adults to acute behavioral and cognitive effects of THC
Murray, C. H., Huang, Z., Lee, R., & de Wit, H. (2022) · Neuropsychopharmacology · doi:10.1038/s41386-022-01281-w · Cited by 46
Kollins, S. H., English, J., Robinson, R., Hallyburton, M., & Chrisman, A. K. (2009) · Psychopharmacology · doi:10.1007/s00213-008-1439-6 · Cited by 48
“Dependent measures—subject-rated effects The Adjective Rating Scale (Oliveto et al. 1992), the Addiction Research Center Inventory (Martin et al. 1971), the Drug-Effect Questionnaire (Rush et al. 2001; Stoops et al. 2004), and a Side Effects Questionnaire (SEQ; Rapoport et al. 1980) were used to assess subjective effe…”
InfluentialBouso, J. C., Pedrero-Pérez, E. J., Gandy, S., & Alcázar-Córcoles, M. Á. (2016) · Human Psychopharmacology: Clinical and Experimental · doi:10.1002/hup.2545 · Cited by 48
Studies with psychedelic drugs in human volunteers
Sellers, E. M., Romach, M. K., & Leiderman, D. B. (2018) · Neuropharmacology · doi:10.1016/j.neuropharm.2017.11.029 · Cited by 42
Diazepam impairs behavioral inhibition but not delay discounting or risk taking in healthy adults.
Acheson, A., Reynolds, B., Richards, J. B., & de Wit, H. (2006) · Experimental and Clinical Psychopharmacology · doi:10.1037/1064-1297.14.2.190 · Cited by 40
Personality and the acute subjective effects of d -amphetamine in humans
Kirkpatrick, M. G., Johanson, C.-E., & de Wit, H. (2013) · Journal of Psychopharmacology · doi:10.1177/0269881112472564 · Cited by 39
Castro Santos, H., & Gama Marques, J. (2021) · Porto Biomedical Journal · doi:10.1097/j.pbj.0000000000000128 · Cited by 37
Hovmand, O. R., Poulsen, E. D., & Arnfred, S. (2024) · Journal of Psychopharmacology · doi:10.1177/02698811231200019 · Cited by 33
“…and the short form load on the following five scales: LSD, (a psychedelic-sen-sitive scale); pentobarbital, chlorpromazine, and alcohol group (a sedative-sensitive scale); benzedrine group; amphetamine; and morphine-benzedrine group (Griffiths et al., 2006; Jasinski, 1977; Martin et al., 1971).”
BackgroundBallard, M. E., Gallo, D. A., & de Wit, H. (2013) · Psychopharmacology · doi:10.1007/s00213-012-2924-5 · Cited by 32
Effects of acute methamphetamine on emotional memory formation in humans: encoding vs consolidation
Ballard, M. E., Weafer, J., Gallo, D. A., & de Wit, H. (2015) · PLOS ONE · doi:10.1371/journal.pone.0117062 · Cited by 20
“As noted above, METH and AMP are similar on physiologic and behavioral measures [31,32].”
BackgroundMartin, W. R. (1973) · Bayer-Symposium · doi:10.1007/978-3-642-87987-6_17 · Cited by 20
Self-citationRose, S. E., Janke, A. L., Strudwick, M. W., McMahon, K. L., Chalk, J. B., Snyder, P., & De zubicaray, G. I. (2006) · Magnetic Resonance in Medicine · doi:10.1002/mrm.20749 · Cited by 20
Strajhar, P., Vizeli, P., Patt, M., Dolder, P. C., Kratschmar, D. V., Liechti, M. E., & Odermatt, A. (2019) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2018.10.016 · Cited by 17
Relative Potency of levo-α-Acetylmethadol and Methadone in Humans under Acute Dosing Conditions
Eissenberg, T., Stitzer, M. L., Bigelow, G. E., Buchhalter, A. R., & Walsh, S. L. (1999) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)38221-7 · Cited by 14
Strain, E. C., Preston, K. L., Stitzer, M. L., Liebson, I. A., & Bigelow, G. E. (1994) · The American Journal on Addictions · doi:10.1111/j.1521-0391.1994.tb00380.x · Cited by 4
Rolan, P., Doolin, E., Paul, D., Crossman, J., Odontiadis, M., Danjou, P., Smith, M., & Papapetropoulos, S. (2026) · Clinical Pharmacology in Drug Development · doi:10.1002/cpdd.1609 · Cited by 3
Metadata
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.